Summary
CME Group Inc. reported revenues of $1,537.6 million for the third quarter of 2025, a decrease of 3% compared to the same period in 2024. This decline was primarily driven by a 5% decrease in clearing and transaction fees, largely due to lower contract volumes across several key asset classes, particularly interest rates and equity indexes, influenced by reduced market volatility. Despite the revenue dip, operating expenses saw a modest increase of 1% to $565.0 million, leading to a slight compression in operating margin. However, net income remained robust at $908.0 million, down only 1% year-over-year, demonstrating the company's operational efficiency. The nine-month period showed a more positive trend with total revenues up 6% to $4,871.9 million and net income increasing by 9% to $2,889.3 million. Significant growth was observed in market data and information services, up 14% for the quarter and 13% year-to-date, indicating successful monetization of data offerings. The company's balance sheet remains strong, with total assets growing substantially, driven by a significant increase in performance bonds and guaranty fund contributions. Cash flows from operations also strengthened considerably, up 18% for the quarter, reflecting effective management of operational activities. The sale of OSTTRA is expected to contribute a substantial gain in the fourth quarter.
Financial Highlights
45 data points| Revenue | $1.54B |
| Operating Expenses | $565.00M |
| Operating Income | $972.60M |
| Net Income | $908.00M |
| EPS (Basic) | $2.49 |
| EPS (Diluted) | $2.49 |
| Shares Outstanding (Basic) | 359.69M |
| Shares Outstanding (Diluted) | 360.42M |
Key Highlights
- 1Total revenues for Q3 2025 decreased by 3% to $1,537.6 million, primarily due to a 5% drop in clearing and transaction fees driven by lower contract volumes.
- 2Despite lower volumes in interest rate and equity index contracts, the average rate per contract increased by 5% in Q3 2025, contributing to a revenue increase of 6% over the nine months.
- 3Market data and information services revenue showed strong growth, up 14% for the quarter and 13% year-to-date, highlighting the increasing value of CME Group's data offerings.
- 4Operating expenses increased by 1% to $565.0 million for the quarter, with notable increases in compensation, benefits, and technology support services, partly offset by lower rent expenses.
- 5Net income for Q3 2025 was $908.0 million, a slight decrease of 1% from the prior year, while year-to-date net income grew 9% to $2,889.3 million.
- 6The company's balance sheet reflects a significant increase in performance bonds and guaranty fund contributions, driving total assets up substantially.
- 7Subsequent to the quarter, CME Group completed the sale of its stake in OSTTRA, which is expected to result in a gain of approximately $300 million in the fourth quarter of 2025.